ContraFect (STU:22R) Cyclically Adjusted Book per Share: €864.66 (As of Sep. 2023)


STU:22R ContraFect Corp STU:22R
28 GF Score
Price €4.98
View Full Analysis

What is ContraFect Cyclically Adjusted Book per Share?

ContraFect STU:22R 28 Cyclically Adjusted Book per Share is €864.66 as of Sep. 2023. GuruFocus rates STU:22R with a GF Score™ of 28/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

ContraFect's adjusted book value per share for the three months ended in Sep. 2023 was €-0.504. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €864.66 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-09), ContraFect's current stock price is €4.984. ContraFect's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was €864.66. ContraFect's Cyclically Adjusted PB Ratio of today is 0.01.


ContraFect  (STU:22R) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

ContraFect's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.984/864.66
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


ContraFect Cyclically Adjusted Book per Share Related Terms


ContraFect Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for ContraFect's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ContraFect Cyclically Adjusted Book per Share Chart

ContraFect Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 87.95

ContraFect Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.77 87.95 278.21 334.29 864.66

STU:22R vs ADTX, RUBY, NBY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, ContraFect's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ContraFect Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ContraFect's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ContraFect's Cyclically Adjusted PB Ratio falls into.


STU:22R
28GF Score
ContraFect Corp STU:22R
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ContraFect Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ContraFect's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book= Book Value per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.504/307.7890*307.7890
=-0.504

Current CPI (Sep. 2023) = 307.7890.

ContraFect Quarterly Data

Book Value per Share CPI Adj_Book
201312 -1,609.333 233.049 -2,125.454
201403 32.250 236.293 42.008
201406 -2,024.375 238.343 -2,614.217
201409 915.960 238.031 1,184.394
201412 829.880 234.812 1,087.798
201503 779.920 236.119 1,016.652
201506 952.129 238.638 1,228.031
201509 809.677 237.945 1,047.342
201512 828.265 236.525 1,077.818
201603 603.794 238.132 780.412
201606 360.500 241.018 460.372
201609 317.769 241.428 405.114
201612 355.731 241.432 453.503
201703 243.654 243.801 307.603
201706 189.769 244.955 238.447
201709 323.435 246.819 403.331
201712 286.500 246.524 357.700
201803 110.293 249.554 136.031
201806 -66.609 251.989 -81.359
201809 -6.071 252.439 -7.402
201812 49.202 251.233 60.278
201903 156.293 254.202 189.240
201906 82.131 256.143 98.691
201909 38.697 256.759 46.388
201912 72.870 256.974 87.280
202003 40.578 258.115 48.387
202006 36.422 257.797 43.485
202009 44.882 260.280 53.074
202012 29.810 260.474 35.225
202103 105.691 264.877 122.814
202106 96.890 271.696 109.761
202109 91.573 274.310 102.749
202112 88.817 278.802 98.051
202203 55.362 287.504 59.268
202206 24.774 296.311 25.734
202209 -6.370 296.808 -6.606
202212 -18.803 296.797 -19.499
202303 -1.871 301.836 -1.908
202306 -0.096 305.109 -0.097
202309 -0.504 307.789 -0.504

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €864.66 mean?
ContraFect (STU:22R) has a Cyclically Adjusted Book per Share of €864.66 as of Sep. 2023. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ContraFect and its competitors.
Is ContraFect's Cyclically Adjusted Book per Share too high?
ContraFect's current Cyclically Adjusted Book per Share is €864.66. Overall, ContraFect has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does ContraFect's Cyclically Adjusted Book per Share compare to ADTX and RUBY?
ContraFect's Cyclically Adjusted Book per Share of €864.66 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ContraFect and its competitors. ContraFect's current Cyclically Adjusted Book per Share is €864.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ContraFect stock overvalued right now?
ContraFect (STU:22R) has a current Cyclically Adjusted Book per Share of €864.66. The current Cyclically Adjusted Book per Share is €864.66. ContraFect's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For ContraFect (STU:22R), the current Cyclically Adjusted Book per Share is €864.66 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ContraFect Business Description

Address 28 Wells Avenue, 3rd Floor, Yonkers, NY, USA, 10701
ContraFect Corp is a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its DLA product candidate, exebacase, is currently being studied in patients with chronic prosthetic joint infections (PJIs) of the knee due to S. aureus or coagulase-negative Staphylococci, and the next product candidate, CF-370, is designed to target a range of gram-negative bacteria, including P. aeruginosa, K. pneumoniae, and A. baumannii, and has demonstrated potent in vivo activity against these pathogens, even against multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains.
28GF Score

Get the complete analysis for STU:22R

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.98
Price